Abstract 419: Presence of pulmonary tuberculosis impair survival in advancedEGFRmutation lung adenocarcinoma patients receiving epidermal growth factor receptor-tyrosine kinase inhibitor
2016 ◽
Vol 79
(4)
◽
pp. 248
◽
2007 ◽
Vol 13
(3)
◽
pp. 799-805
◽
2020 ◽
2014 ◽
Vol 35
(8)
◽
pp. 915
2003 ◽
Vol 94
(5)
◽
pp. 453-458
◽
2014 ◽
Vol 21
(S4)
◽
pp. 610-618
◽